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ORIGINAL ARTICLE INFECTIOUS DISEASESThe association of uterine cervical microbiota with an increased risk for
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of Obstetrics and Gynaecology, Korea University College of Medicine, Seoul and 6) Division of Cancer Biology, National Cancer Centre, Goyang-siAbstractRecent studies have suggested potential roles of the microbiome in cervicovaginal diseases. However, there has been no report on the
cervical microbiome in cervical intraepithelial neoplasia (CIN). We aimed to identify the cervical microbiota of Korean women and assess
the association between the cervical microbiota and CIN, and to determine the combined effect of the microbiota and human
papillomavirus (HPV) on the risk of CIN. The cervical microbiota of 70 women with CIN and 50 control women was analysed using
pyrosequencing based on the 16S rRNA gene. The associations between speciﬁc microbial patterns or abundance of speciﬁc microbiota
and CIN risk were assessed using multivariate logistic regression, and the relative excess risk due to interaction (RERI) and the synergy
index (S) were calculated. The phyla Firmicutes, Actinobacteria, Bacteroidetes, Proteobacteria, Tenericutes, Fusobacteria and TM7 were
predominant in the microbiota and four distinct community types were observed in all women. A high score of the pattern characterized
by predominance of Atopobium vaginae, Gardnerella vaginalis and Lactobacillus iners with a minority of Lactobacillus crispatus had a higher
CIN risk (OR 5.80, 95% CI 1.73‒19.4) and abundance of A. vaginae had a higher CIN risk (OR 6.63, 95% CI 1.61‒27.2). The synergistic
effect of a high score of this microbial pattern and oncogenic HPV was observed (OR 34.1, 95% CI 4.95‒284.5; RERI/S, 15.9/1.93). A
predominance of A. vaginae, G. vaginalis and L. iners with a concomitant paucity of L. crispatus in the cervical microbiota was associated
with CIN risk, suggesting that bacterial dysbiosis and its combination with oncogenic HPV may be a risk factor for cervical neoplasia.
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p://dx.doi.org/10.1016/j.cmi.2015.02.026IntroductionThe importance of the microbiota in health maintenance or
disease susceptibility is well known; the gut microbiota is
known to control the absorption of nutrients [1]. Imbalance
in the gut is associated with Crohn’s disease, type 2 diabetes
and chronic allergies [2], for which dysbiosis, not a single
pathogen change but shifts in the relative abundance of mi-
crobes, has long been suggested. Furthermore, the association
of microbial dysbiosis with several cancer types has been
suggested in areas surrounded by mucosal membranes whereious Diseases. Published by Elsevier Ltd. All rights reserved
CMI Oh et al. Microbiome in cervical intraepithelial neoplasia 674.e2bacteria live densely [3]. Although only modest effects of
dysbiosis on cancer have been presented so far, the long
duration of dysbiosis and possible combined effects with
other risk factors suggest greater clinical implications [4].
Although human papillomavirus (HPV) has been the major
risk for cervical precancerous lesions or cancer [5]; recently,
the potential role of the cervicovaginal microbiome in cervical
cancer through the elevation of pH has been reported [6]. In
addition, the role of the cervicovaginal microbiome in HPV
infection has also been reported [7], suggesting a possible role
in cervical cancer through potentiation of HPV infection.
Although there have been reports on the microbiome in
premenopausal or postmenopausal women [8], and in bac-
terial vaginosis (BV) [9], no study on the microbiome related
to cervical precancerous lesions or cancer has been pre-
sented. The purpose of this study was to assess the associa-
tion between cervical intraepithelial neoplasia (CIN) the and
cervical microbiota identiﬁed using pyrosequencing.Materials and methodsStudy participants and design
The Korean HPV cohort study, which was established to
identify epidemic, genetic, viral and ecological factors associ-
ated with the development of cervical neoplasia in Korean
women, recruited 1096 women, aged 18–65 years, from
March 2006 to the present. The study participants were
randomly selected from the gynaecological oncology clinics of
six tertiary medical centres in Korea. Detailed information
regarding the inclusion/exclusion criteria and the design of the
baseline measurements for the HPV cohort were presented in
a previous study [10]. All study participants provided written
informed consent in accordance with good clinical practices.
Cervical swabs were collected for a Papanicoaou smear test.
Immediately after sampling, each cervix brush (Rovers Medical
Devices, Oss, the Netherlands) was rinsed in a vial of Pre-
servCyt solution (Cytyc Co., Marlborough, MA, USA), and the
vial was placed in a Thin Prep Processor (Cytyc Co.). A second
swab was collected for high-risk (HR)-HPV DNA detection and
microbiota analysis using a Cervical Sampler Brush (Digene Co.
Gaithersburg, MD, USA). Half of the second swab was used
immediately for HR-HPV DNA detection and the other half
was stored at −80°C for subsequent DNA extraction, for
2 months up to a maximum of 5 years. A total of 125 women
were randomly selected from the 1096 enrolled women, and
baseline samples obtained from 120 women (50 controls, 70
with CIN) were analysed; for ﬁve of the samples, metagenomic
DNA extraction failed. This study was approved by the Insti-
tutional Review Board of the Korean National Cancer CentreClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and In(NCCNCS-06-062) and by the ethics committees of the
Korean National Cancer Centre and Korea University Guro
Hospital.
Cytological screening and HR-HPV DNA detection
The cervical cytological ﬁndings were classiﬁed according to the
Bethesda system [11]. HPV DNA detection was performed
using the commercially available Digene Hybrid capture II DNA
Test (Qiagen, Gaithersburg, MD, USA). The results of a
chemiluminescent HPV DNA test were measured in relative
light units (RLU) with a probe designed to detect 13 types of
HR-HPV. The test results were read as positive at concentra-
tions of 1 pg/mL or greater than the RLU/cut-off ratio (RLU of
specimen/mean RLU of two positive controls).
DNA extraction and pyrosequencing
Metagenomic DNA samples were extracted using the Fast
DNA SPIN extraction kits (MP Biomedicals, Santa Ana, CA,
USA). Target fragments of the 16S rRNA gene corresponding
to the V1–V3 regions were ampliﬁed using bar-coded primers.
Ampliﬁcations were performed in a ﬁnal volume of 50 μL
containing 10 × Taq buffer, a dNTP mixture (Takara, Shiga,
Japan), 10 μM of the bar-coded fusion primers, and 2 U of Taq
polymerase (ExTaq, Takara). The ampliﬁcation conditions and
pyrosequencing procedure have been previously described
[12]. The beads recovered following emulsion PCR were
deposited on a 454 Pico Titer Plate, and sequencing was per-
formed using a Roche/454 GS Junior system (Roche, Branford,
CT, USA).
Pyrosequencing data analysis
The raw sequences were sorted using their unique barcodes,
and low-quality reads (with an average quality score <25 or a
read length <300 bp) were removed [12]. The primer se-
quences were trimmed using a pairwise sequence alignment,
and sequences were clustered to correct for sequencing er-
rors. Representative sequences in each cluster were identiﬁed
using EzTaxon-e, a public database that contains sequences of
the 16S rRNA genes of species type strains, and the taxo-
nomic positions of relevant uncultured sequences were
identiﬁed [13] using the highest pairwise similarity among the
BLASTN results. Chimeric sequences were detected and
removed by the UCHIME algorithm, which detects chimeric
sequences by alignment of a query sequence with two parent
sequences in a reference database [14], and the
diversity indices were calculated using the MOTHUR program.
The heat-map analysis was performed using the MULTI-EXPERI-
MENT VIEWER. Pyrosequencing reads are available in the
EMBL SRA database (http://www.ebi.ac.uk/ena/data/view/
PRJEB5760).fectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 674.e1–674.e9
FIG. 1. Comparison of the cervical microbiota of women at the species level using heat-map analysis. The relative abundance of each species was
represented by a colour; red indicates a high proportion and blue indicates a low abundance. Hierarchical clustering of the cervical microbiota was
performed using the Spearman’s correlation.
674.e3 Clinical Microbiology and Infection, Volume 21 Number 7, July 2015 CMIQuantitative real-time PCR assays
Genomic DNA was extracted with 25 KU/mL mutanolysin
(Sigma-Aldrich, St Louis, MO, USA) using a QIAamp DNA mini
kit (Qiagen, Valencia, CA, USA), as described previously [15].
The DNA targets, primers, probe sequences, oligonucleotides
used for PCR, and the ampliﬁcation conditions are shown in the
Supporting information (Table S1) [16].
Statistical analysis
Factor analysis was performed on the 18 most predominant
species using STATA 12.0 (Stata Co., College Station, TX,
USA). Among the 18 microbial patterns identiﬁed, ten had an
eigenvalue >1. The pattern matrix (i.e. the correlation co-
efﬁcients between the species and the patterns) is provided in
the Supporting information (Table S2). The Wilcoxon rank-
sum and Spearman’s rank correlation tests were performed
to measure differences between two groups and theClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectdependence between two variables, respectively. Logistic
regression analysis was performed after adjustment for age,
marital status, menopausal status, oral contraceptive use,
smoking habit and HR-HPV infection. Risk estimates are pre-
sented as OR with 95% CI. To determine biological in-
teractions, ORs for additive scale and multiplicative terms were
estimated, and the relative excess risk due to interaction (RERI)
and synergy index (S) were calculated as described previously
[17]. Values for RERI >0 and S >1 indicate the presence of a
synergistic effect.ResultsGeneral characteristics of study participants
Women with CIN 1 (n = 55) and CIN 2 or 3 (n = 15) were
accrued, along with control women with normal cytologyious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 674.e1–674.e9
TABLE 1. Odds ratios for cervical intraepithelial neoplasia (CIN) according to the scores of the risky microbial pattern and the
relative abundance of four species
OR and 95% CI for CINsc
Groups Median pa T1 (40)b T2 (40) T3 (40) p for trendd
Score of the risky microbial pattern Controls 0.03
CIN 0.33 0.007 1 (ref.) 1.85 (0.65–5.31) 5.80 (1.73–19.4) 0.004
Groups Median p T1 (67) T2 (27) T3 (26) p for trend
Relative abundance of A. vaginae Controls 0.00
CIN 0.05 0.003 1 (ref.) 3.85 (1.22–12.2) 6.63 (1.61–27.2) 0.003
Groups Median p T1 (68) T2 (26) T3 (26) p for trend
Relative abundance of G. vaginalis Controls 0.00
CIN 0.01 0.044 1 (ref.) 1.25 (0.41–3.76) 3.21 (0.95–10.8) 0.067
Groups Median p T1 (40) T2 (40) T3 (40) p for trend
Relative abundance of L. iners Controls 1.08
CIN 3.36 0.188 1 (ref.) 3.16 (0.99–10.0) 2.49 (0.88–7.08) 0.089
Groups Median p T3 (33) T2 (33) T1 (54) p for trend
Relative abundance of L. crispatus Controls 0.02
CIN 0.01 0.270 1 (ref.) 3.18 (0.96–10.5) 1.88 (0.65–5.38) 0.339
ap value was from Wilcoxon rank-sum test and p < 0.05 was regarded as signiﬁcant.
bThe scores of the risky microbial pattern and the relative abundances (%) of Atopobium vaginae, Gardnerella vaginalis, Lactobacillus iners and Lactobacillus crispatus were divided into
three equal-sized subsets; T1 (tertile 1, low), T2 (tertile 2, medium) and T3 (tertile 3, high). The numbers of women included in each tertile are provided in brackets. p is for trend of
OR of the tertiles and p < 0.05 was regarded as signiﬁcant.
cOdds ratios and 95% CI of all variables were estimated by T1 as a reference category except those of the relative abundance of L. crispatus estimated by T3. All variables in this table
were adjusted for age, marital status, menopausal status, oral contraceptive use and smoking habit as categorical types.
dp is for trend of odds ratios of the tertiles and p < 0.05 was regarded as signiﬁcant.
CMI Oh et al. Microbiome in cervical intraepithelial neoplasia 674.e4(n = 25) or atypical squamous cells of undetermined signiﬁ-
cance (ASCUS; n = 25) (see Supporting information, Table S2).
No signiﬁcant difference was observed between control
women and women with CIN except HR-HPV infection (p
0.002).
Cervical microbiota among participants
In total, 1 118 398 high-quality reads were analysed and an
average of 74.1 operational taxonomic units (OTUs) per sample
was observed. Seven phyla—Firmicutes, Actinobacteria, Bac-
teroidetes, Proteobacteria, Tenericutes, Fusobacteria, and
candidate division TM7—were dominant (see Supporting
information, Fig. S1). Although Firmicutes was the predomi-
nant phylum in most women (n = 75), Bacteroidetes, Actino-
bacteria, Tenericutes and Proteobacteria were also prevalent
(n = 45). The composition of the dominant phyla was not
clearly distributed by HPV infection status or histological
grades. However, the abundances of Bacteroidetes, Actino-
bacteria, Tenericutes and Proteobacteria were higher in HPV-
positive women (n = 34) than in HPV-negative women (14).
Actinobacteria was observed more predominantly in women
with CIN (n = 5) than in controls (6).
The OTU number was higher in women with CIN than
controls in postmenopausal women, but lower in women with
CIN than controls in premenopausal women (see Supporting
information, Fig. S2a). The OTU number was higher in HPV-
negative than HPV-positive women irrespective of meno-
pausal status (see Supporting information, Fig. S2b). The OTUClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Innumber in control women and women with CIN was similar in
HPV-negative women, but it was higher in controls than in
women with CIN in HPV-positive women (see Supporting
information, Fig. S2c).
Cervical microbiota was distributed into four clusters using
heat-map analysis at the species level (Fig. 1). Lactobacillus iners
was predominant in cluster I; Atopobium vaginae, Prevotella bivia,
Lactobacillus fornicalis, Pseudomonas poae and Gardnerella vaginalis
were dominant members in cluster II; L. iners and Lactobacillus
crispatus were dominant in cluster III; and L. iners, A. vaginae,
P. bivia, Prevotella amnii, and uncultured bacteria ADGP (Meg-
asphaera genomosp. type_1 str. 28L) were abundant in cluster
IV. Although the clusters were not clearly separated by HPV
infection or histology grade, most HPV-negative women carried
L. iners and L. crispatus as the dominant members. There were
more HPV-positive women in clusters II and IV, and A. vaginae,
P. bivia, L. fornicalis, Pseudomonas poae and G. vaginalis were
higher in cluster II than in cluster IV.
Risky microbial pattern associated with CIN risk
The individual scores for the ten microbial patterns each ob-
tained from factor analysis were used for the following step.
Only the third pattern showed a signiﬁcant difference in its
score between controls and women with CIN (p 0.007)
(Table 1 and see Supporting information, Table S3). The OR of
a high tertile of this pattern score was 5.80 (95% CI 1.73–19.4)
compared with a low tertile. This risky microbial pattern was
characterized by a predominance of A. vaginae, L. iners andfectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 674.e1–674.e9
674.e5 Clinical Microbiology and Infection, Volume 21 Number 7, July 2015 CMIG. vaginalis and a concomitant paucity of L. crispatus (see
Supporting information, Table S4). The women with a high
tertile of this pattern score had a high proportion of A. vaginae
(mean 28.8%) and G. vaginalis (5.6%), and a low proportion of
L. crispatus (0.95%) (Fig. 2a). Lactobacillus iners predominated in
women with the medium to high scores (21.2%) (Fig. 2b).
Association of A. vaginae, G. vaginalis, L. iners and
L. crispatus with CIN risk
There was a signiﬁcant median difference in relative abundance
of A. vaginae between controls and women with CIN (p 0.003)
(Table 1). The OR for CIN risk of a high tertile of A. vaginae
relative abundance was 6.63 (95% CI 1.61‒27.2) compared with
the low tertile. The abundances of L. iners and L. crispatus were
not different between controls and women with CIN, and high
tertiles of those species were not associated with CIN. How-
ever, some women with CIN had a high proportion of L. iners
(Fig. 1) and some had complete absence of or low L. crispatus.FIG. 2. The distribution of four species (Gardnerella vaginalis, Atopobium vagin
the relative abundance of four species according to the score of the risky mic
L. crispatus). (b) Box plots show a signiﬁcant difference in the relative abunda
p < 0.001, (b) p < 0.001, (c) p = 0.0361, (d) p < 0.001 in the Kruskal–Walli
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectSynergistic effect of the risky microbial pattern and
HR-HPV on CIN risk
The OR for CIN risk of HR-HPV-positive women with a high
score of the risky microbial pattern was 34.1 (95% CI
4.95–234.5), compared with HR-HPV-negative women with a
low score. The RERI and S (15.9 and 1.93), and p value for the
multiplicative term (p 0.018) also showed a synergistic effect
between the two (Table 2). The OR of HR-HPV-positive
women with A. vaginae in the cervix was 29.9 (95% CI
5.49–163.0), compared with HR-HPV-negative women without
A. vaginae (RERI and S, 15.4 and 2.14; p 0.002). The OR of HR-
HPV-positive women with L. iners in the cervix was 10.8 (95%
CI 1.65–70.9) (RERI and S, 7.39 and 4.06; p < 0.001).
Quantitative real-time PCR for A. vaginae and
L. crispatus
To compare the results obtained from the quantitative real-
time PCR assay and the pyroseqencing for A. vaginae andae, Lactobacillus iners and Lactobacillus crispatus). (a) Area distribution for
robial pattern (red, G. vaginalis; orange, A. vaginae; yellow, L. iners; green,
nce of each species between the tertiles of the risky pattern score; (a)
s rank test.
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 674.e1–674.e9
TABLE 2. Synergistic joint effect of the risky microbial pattern with high-risk human papillomavirus (HR-HPV) infection on the
increase of cervical intraepithelial neoplasia risk
Joints Symbol a N w/wo b OR (95% CI) c RERI/S d
Risky microbial pattern (a) and HR-HPV (b) 0, 0 5/19 1 (ref.) 15.9/1.93
0, 1 42/24 8.32 (2.18–31.7)
1, 0 7/3 10.8 (1.71–68.8)
1, 1 16/4 34.1 (4.95–234.5)
p for trend e <0.001
p for interaction (a × b) f 0.018
Atopobium vaginae (a) and HR-HPV (b) 0, 0 4/15 1 (ref.) 15.4/2.14
0, 1 27/21 7.74 (1.70–35.3)
1, 0 8/7 7.76 (1.26–48.0)
1, 1 31/7 29.9 (5.49–163.0)
p for trend <0.001
p for interaction (a × b) 0.002
Gardnerella vaginalis (a) and HR-HPV (b) 0, 0 7/18 1 (ref.) 1.23/1.19
0, 1 27/16 5.17 (1.52–17.7)
1, 0 5/4 3.14 (0.55–18.1)
1, 1 31/12 8.55 (2.34–31.2)
p for trend 0.001
p for interaction (a × b) 0.031
Lactobacillus iners (a) and HR-HPV (b) 0, 0 2/6 1 (ref.) 7.39/4.06
0, 1 12/11 2.87 (0.43–19.1)
1, 0 10/16 1.55 (0.24–10.1)
1, 1 46/17 10.8 (1.65–70.9)
p for trend <0.001
p for interaction (a × b) <0.001
Lactobacillus crispatus (a) and HR-HPV (b) 1, 0 7/14 1 (ref.) −2.28/0.66
1, 1 30/15 6.82 (1.79–26.0)
0, 0 5/8 1.92 (0.40–9.11)
0, 1 28/13 5.45 (1.48–20.1)
p for trend 0.120
p for interaction (a × b) 0.250
aThe symbol ‘0’ corresponds to the low score of the risky microbial pattern (low to medium tertile), the absence of indicated microbial species (the relative abundance = 0) and non-
HPV infection. The symbol ‘1’ stands for the high risky microbial pattern score (high tertile), the presence of that (the relative abundance > 0) and HPV infection.
bThe number of women with/without cervical intraepithelial neoplasia (CIN) lesions was presented.
cOdds ratio (OR) was estimated after adjustment for age, marital status, menopausal status, oral contraceptive use and smoking history as categorical variables.
dThe biological interaction of the joint based on the additive model was investigated using relative excess risk due to interaction (RERI) and synergy index (S). RERI >0 and S > 1
indicate a synergistic effect.
ep is for the linear trend of odds ratios according to the order of combination provided by the logistic regression analysis.
fP is for the interaction provided by the logistic regression for the multiplicative terms (a × b).
CMI Oh et al. Microbiome in cervical intraepithelial neoplasia 674.e6L. crispatus, the ratio of the two species (log-transformed) was
used (Fig. 3). The statistical dependence between the two ratios
was signiﬁcantly high (Spearman’s correlation coefﬁcient 0.868;
p 0.001). There was a signiﬁcant difference between controls
and women with CIN in both the ratios obtained from pyro-
sequencing (p 0.016) and real-time PCR (p 0.003).DiscussionThis study showed that a cervical microbial composition char-
acterized by a predominance of A. vaginae, G. vaginalis and
L. iners with a concomitant paucity of L. crispatus is associated
with a higher risk of CIN. The predominance of A. vaginae was a
major contributor to this risk. Furthermore, a synergistic
interaction between this microbial pattern and HR-HPV infec-
tion that robustly increased the risk was observed.
In most women, L. crispatus and L. iners were the dominant
cervical microbiota. These two species were also found to be
predominant in previous studies of the vaginal microbiota of
Asian women [8,18]. In contrast to previous reports, A
vaginae, G. vaginalis, P. bivia and Pneumococcus poae were the
dominant species in several women in this study. In previousClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Inreports, a higher proportion of Proteobacteria, a lower pro-
portion of Firmicutes, and a greater diversity of bacteria were
observed in postmenopausal women than in premenopausal
women [8]. However, in the present study, various microbial
compositions and a higher proportion of Firmicutes were
observed in postmenopausal women. In addition, higher
numbers of OTU were detected in premenopausal women
than in postmenopausal women. This difference may be
attributed to differences in the target region of 16S rRNA
genes analysed or in sequencing methods [19]. Although these
differences could produce disparities among the results of
studies of microbiota, the predominant members of the cer-
vical microbiota detected here were consistent with those
detected in previous studies that used different target regions
[19]. The similarity of the results is a result of the relatively
low diversity of the cervical microbiota, compared with
microbiota from other parts of the human body. Therefore,
various other factors, including sample collection techniques,
temporal shifts in the microbiota during the menstrual cycle,
hygiene practices, glycogen levels and host genetic factors
could be associated with individual variation; these variations
may underlie the discrepancy observed between the results of
this study and previous studies [8,18–21].fectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 674.e1–674.e9
FIG. 3. Quantitative real-time PCR assay of Atopobium vaginae and Lactobacillus crispatus. Log of the ratio of A. vaginae and L. crispatus provided from
pyrosequencing (the relative abundances) (a) and real-time PCR (equivalent/μL) (b). A Spearman’s rank correlation test was performed for measuring
the statistical dependence between two variables; rank correlation coefﬁcient = 0.868, p < 0.001. The p value was from the Wilcoxon rank-sum test
for controls and women with cervial intraepithelial neoplasia (CIN).
674.e7 Clinical Microbiology and Infection, Volume 21 Number 7, July 2015 CMIClusters I and III contained a greater abundance of L. iners
and L. crispatus. Clusters II and IV contained various bacteria as
the predominant members, but differed in composition. These
clusters were similar to previously reported community state
types [18]. Clusters I and III were similar to community state
types I and III described in a previous report [18]. Cluster II
was similar to state type IV_B, and cluster IV was similar to
type IV_A. Diverse microbial associations containing high
proportions of Atopobium, Prevotella, Sneathia and Gardnerella
have been reported to be related to BV [22]. Although the
diverse community detected in clusters II and IV could be
related to BV, diverse bacterial communities do not always
have persistently high Nugent scores [21]. A high Nugent
score is one of the methods available for diagnosis of BV, but
it is not routinely used by physicians because of its inaccuracy.
Molecular quantiﬁcation of A. vaginae and G. vaginalis shows
a higher reproducibility for diagnosis of BV than Nugent
scores [16].
Although conﬁrmation using other diagnostic tests is
required, BV may be involved in the microbial composition
associated with a high risk of CIN identiﬁed in the study. To
date, several studies have explored the role of BV in cervical
neoplasia; they have reported conﬂicting ﬁndings. In one pro-
spective study, the CIN rate and the quantity of nitrosamines
produced in women with BV did not differ from those in
women with normal ﬂora [23]. Another longitudinal study re-
ported no inﬂuence of abnormal ﬂora on the presence of
atypical endocervical cells [24]. In contrast, Nam et al. showed a
signiﬁcant correlation between BV and CIN, regardless of
severity [25]. Furthermore, a recently published systemicClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectreview and meta-analysis showed a positive correlation be-
tween BV and CIN [26]. However, these ambivalent results
may be attributed to the different tools used in the diagnosis of
BV. Of the above-mentioned studies, two used a BV diagnosis
with three other measurements, including pH, clue cells after
Gram stain, and a positive amine or whiff test [23,25], and the
other used the Nugent scale [24]. Although the correlation
between BV and CIN remains to be determined, our results are
in support of such a correlation.
In this study, the women with the highest risk of CIN
showed low levels of L. crispatus. Hydrogen peroxide-producing
Lactobacilli are present in 96% of women with a normal vaginal
bacterial community [27]. Species in the genus Lactobacillus
maintain a low pH by producing lactic acid. Lactobacillus crispatus
was more strongly associated with a low vaginal pH than L. iners,
suggesting that these two species differ in ecological function
[9]. Whereas a high abundance of L. crispatus was detected in
the low-risk group in this study, L. iners was abundant in the
medium-risk group, showing that this population indicates a
susceptibility to CIN. Lactobacillus iners has been reported to
become a predominant part of the microbial community when
the vaginal microbiota transitions between abnormal and
normal states [28]. HPV can alter mucosal metabolism and host
immunity, and can induce changes in the vaginal microbiota
[29]. Atopobium vaginae also stimulates an innate immune
response from vaginal epithelial cells, leading to the secretion of
interleukin, and the production of defending protein β-defensin
(BD) [30]. Increased protein and mRNA expression of human
BD2 and human BD3 was also observed in the genital condy-
lomata acuminata of the vulvovaginal tract, induced by HPVious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 674.e1–674.e9
CMI Oh et al. Microbiome in cervical intraepithelial neoplasia 674.e8[31]. Colonization of the vaginal epithelia by A. vaginae and
G. vaginalis induced production of interleukin-8 and regulated
on activation, normal T-cell expressed and secreted (RANTES),
and ampliﬁed the pro-inﬂammatory response to both mem-
brane lipophosphoglycan/ceramide–phosphoinositol–glycan
core and Trichomonas vaginalis [32]. Levels of RANTES and
macrophage inﬂammatory protein-1β were signiﬁcantly higher
in the cervical mucosa of HIV/HPV-co-infected individuals than
in HPV-mono-infected individuals [33]. In a recent survey of the
interactions between HPV types in healthy individuals, more
than 50% of healthy women showed co-infection with two to
three HPV types in vaginal tissue [34]. Evidence of complex
interactions between viruses and immune regulators, bacterial
ﬂora and immune regulators, and co-infection with multiple
viruses in the genital tract is accumulating [30–34]. Our ﬁndings
demonstrated an interaction between the bacterial ﬂora and
HR-HPV-type infections, and a possible association between
this interaction and clinical cervical neoplasia. The synergistic
effect that increases the risk of CIN noted between a pre-
dominance of BV-related bacteria and a concomitant HPV
infection could be caused by a robust response of the same
immune regulators.
This study demonstrated that bacterial dysbiosis, character-
ized by a predominance of A. vaginae, G. vaginalis and L. iners and
a concomitant paucity of L. crispatus, in its combination with
oncogenic HPV may be a risk factor for cervical neoplasia.
Although further studies using a large number of women with
CIN 2 or CIN 3 and considering other latent sexually trans-
mitted organisms with no symptoms are required, we suggest
that a monitoring programme for the relative distribution of
these species in the cervicovaginal system could be helpful for
the effective prevention of cervical precancerous lesions.Transparency declarationThe authors have no conﬂict of interest.AcknowledgementsThis research was supported by grants from the National
Cancer Centre in Korea (1110320, 1310360).Appendix A. Supplementary dataSupplementary data related to this article can be found at http://
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